HilleVax, Inc.
HLVX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $100 | $72 | $103 | $87 |
| - Cash | $59 | $47 | $154 | $104 |
| + Debt | $24 | $24 | $25 | $25 |
| Enterprise Value | $65 | $49 | -$27 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$6 | -$33 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$6 | -$34 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.11 | -0.12 | -0.68 | -0.52 |
| % Growth | 8.3% | 82.4% | -30.8% | – |
| Operating Cash Flow | -$1 | -$13 | -$18 | -$28 |
| Capital Expenditures | $0 | $0 | -$0 | -$2 |
| Free Cash Flow | -$1 | -$13 | -$18 | -$30 |